Does RUCAPARIB CAMSYLATE Cause Dyspnoea? 388 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 388 reports of Dyspnoea have been filed in association with RUCAPARIB CAMSYLATE (Rubraca). This represents 4.7% of all adverse event reports for RUCAPARIB CAMSYLATE.
388
Reports of Dyspnoea with RUCAPARIB CAMSYLATE
4.7%
of all RUCAPARIB CAMSYLATE reports
14
Deaths
111
Hospitalizations
How Dangerous Is Dyspnoea From RUCAPARIB CAMSYLATE?
Of the 388 reports, 14 (3.6%) resulted in death, 111 (28.6%) required hospitalization, and 2 (0.5%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUCAPARIB CAMSYLATE. However, 388 reports have been filed with the FAERS database.
What Other Side Effects Does RUCAPARIB CAMSYLATE Cause?
Fatigue (2,494)
Nausea (2,219)
Malignant neoplasm progression (1,162)
Decreased appetite (787)
Constipation (763)
Diarrhoea (759)
Vomiting (759)
Asthenia (660)
Adverse event (571)
Carbohydrate antigen 125 increased (562)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which RUCAPARIB CAMSYLATE Alternatives Have Lower Dyspnoea Risk?
RUCAPARIB CAMSYLATE vs RUFINAMIDE
RUCAPARIB CAMSYLATE vs RUPATADINE
RUCAPARIB CAMSYLATE vs RUXOLITINIB
RUCAPARIB CAMSYLATE vs SABRIL
RUCAPARIB CAMSYLATE vs SACCHAROMYCES CEREVISIAE